1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
BioVision, Inc. Logo

BioVision Introduces Two New Assay Kits Granzyme B Activity & Granzyme B Inhibitor Screening Kit

BioVision is thrilled to introduce two brand new assay kits: Granzyme B Activity Kit, a highly sensitive kit for measuring Granzyme B Activity and Granzyme B Inhibitor Screening Kit, a high-throughput kit to screen/characterize Granzyme B inhibitors.

 
PRLog - Jan. 30, 2013 - MILPITAS, Calif. -- Granzyme B (GZMB, EC number 3.4.21.79) also known as Granzyme-2 is a serine protease stored in the granules of activated cytotoxic T cells and NK cells. Upon target cell contact, Granzyme B is directionally exocytosed and with the assistance of perforin enters the target cell. With its unique substrate specificity (Granzyme B prefers an aspartic acid residue at the P1 site of its substrates); Granzyme B processes and activates various pro-caspases thereby inducing apoptosis in the target cell. Granzyme B acts at multiple points to initiate the death of the offending cell. Studies of the granzyme B death receptor and internal signaling pathways may lead to critical advances in cell transplantation and cancer therapy.

Granzyme B Activity Assay Kit [Cat # K168-100 (100 Assays)]: In BioVision’s Granzyme B Activity Assay Kit, active human Granzyme B enzyme hydrolyzes the specific substrate to release the quench of fluorescent group, which can be detected fluorometrically at Ex/Em = 380/500 nm.

Key Features and Benefits of the Kit
-
Simple & Sensitive
- Rapid, Reliable & Accurate
- Fluorometric quantification (Ex/Em = 380/500 nm)
- Measure Granzyme B activity in various biological samples or purified Granzyme B
- Kit provides ample reagents to perform 100 assays in a 96-well plate format

For more information, please visit, http://www.biovision.com/granzyme-b-activity-assay-kit-60...  

Granzyme B Inhibitor Screening Kit [Cat # K169-100 (100 Assays)]: In BioVision’s Granzyme B Inhibitor Screening Kit, active human Granzyme B enzyme hydrolyzes the specific substrate to release the quench of fluorescent group, which can be detected fluorometrically at Ex/Em = 380/500 nm. In the presence of potent Granzyme B Inhibitor, the hydrolyzation of substrate will be impeded. Inhibitor control, Ac-IEPD-CHO is included to compare the efficacy of test inhibitors.

Key Features and Benefits of the Kit
- Simple and Reliable
- Rapid, Convenient and High-Throughput Suitable
- Fluorometric (Ex/Em = 380/500 nm) quantification
- Screen/characterize/study Granzyme B inhibitors
- Kit provides ample reagents to perform 100 assays in a 96 well plate format

For more information, please visit, http://www.biovision.com/granzyme-b-inhibitor-screening-k...

--- End ---

Click to Share

Contact Email:
***@biovision.com Email Verified
Source:BioVision, Inc.
Phone:408-493-1800
Zip:95035
Location:Milpitas - California - United States
Industry:Biotech
Tags:granzyme b kit, granzyme b inhibitor-screening, granzyme b activity, granzyme b assay, granzyme b
Shortcut:prlog.org/12070102
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share